Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index

In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast canc...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 87; no. 1; pp. 8 - 14
Main Authors HAWKINS, R. A, TESDALE, A. L, HULME, M. J, MILLER, W. R, PRESCOTT, R. J, FORSTER, T, MCINTYRE, M. A, BAKER, P, JACK, W. J. L, CHETTY, U, DIXON, J. M, KILLEN, M. E
Format Journal Article
LanguageEnglish
Published Basingstoke Nature Publishing Group 01.07.2002
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In 1990, 215 patients with operable breast cancer were entered into a prospective study of the prognostic significance of five biochemical markers and 15 other factors (pathological/chronological/patient). After a median follow-up of 6.6 years, there were 77 recurrences and 77 deaths (59 breast cancer-related). By univariate analysis, patient outcome related significantly to 13 factors. By multivariate analysis, the most important of nine independent factors were: number of nodes involved, steroid receptors (for oestrogen or progestogen), age, clinical or pathological tumour size and grade. Receptors and grade exerted their influence only in the first 3 years. Progestogen receptors (immunohistochemical) and oestrogen receptors (biochemical) were of similar prognostic significance. The two receptors were correlated (r=+0.50, P=0.001) and displaced each other from the analytical model but some evidence for the additivity of their prognostic values was seen when their levels were discordant.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Current address: c/o Miss Monica McGill, Edinburgh Breast Unit, Western General Hospital, Edinburgh EH4 2XU, UK
ISSN:0007-0920
1532-1827
DOI:10.1038/sj.bjc.6600335